Patents Assigned to VALIRX PLC
  • Patent number: 10023612
    Abstract: The invention provides a molecule that inhibits or prevents an interaction between a Src family kinase and an androgen or estradiol receptor, for use in preventing or treating a non-cancerous condition in which an activity of AR and/or ER is a contributory factor in a subject, or for use in preventing or treating a cancerous condition in which an activity of AR and/or ER is a contributory factor in a subject who wishes to preserve fertility, or for use in preventing or treating a gynecological condition in which an activity of AR and/or ER is a contributory factor in a subject.
    Type: Grant
    Filed: November 1, 2012
    Date of Patent: July 17, 2018
    Assignee: VALIRX PLC
    Inventors: Mark Eccleston, Satu Vainikka, George Steven Morris